Table 1.

Validation AUROC and comparison among L-GrAFT₁₀, L-GrAFT₇, EASE, MEAF, and EAD.

	AUROC (95% CI)					L-GrAFT10 vs. MEAF	L-GrAFT7 vs. MEAF	L-GrAFT10 vs. EAD	L-GrAFT7 vs. EAD	EASE vs. EAD
	L-GrAFT10	L-GrAFT7	EASE	MEAF	EAD	P-value	P-value	P-value	P-value	P-value
ALL PATIENTS
Patient survival
3 month	0.88 (0.82–0.94)	0.87 (0.81–0.93)	0.84 (0.77–0.92)	0.77 (0.69–0.86)	0.75 (0.68–0.81)	0.01	0.01	<0.001	<0.001	0.01
6 month	0.80 (0.72–0.88)	0.80 (0.72–0.88)	0.78 (0.70–0.86)	0.74 (0.65–0.82)	0.71 (0.64–0.78)	0.16	0.07	0.005	0.001	0.03
12 month	0.71 (0.63–0.79)	0.71 (0.63–0.79)	0.70 (0.63–0.78)	0.68 (0.61–0.75)	0.64 (0.57–0.71)	0.50	0.44	0.02	0.02	0.03
Graft survival
3 month	0.88 (0.82–0.94)	0.87 (0.81–0.94)	0.85 (0.77–0.92)	0.78 (0.69–0.87)	0.75 (0.68–0.81)	0.01	0.01	<0.001	<0.001	0.009
6 month	0.80 (0.73–0.88)	0.81 (0.73–0.88)	0.79 (0.71–0.87)	0.74 (0.66–0.82)	0.71 (0.64–0.78)	0.15	0.07	0.003	<0.001	0.02
12 month	0.71 (0.63–0.79)	0.71 (0.63–0.80)	0.71 (0.64–0.78)	0.69 (0.62–0.76)	0.64 (0.57–0.71)	0.49	0.44	0.01	0.02	0.02